http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201309723-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-36 |
filingDate | 2012-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b8d7800a684adcacb119e1bf80cb9e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cb2a65c678f2ea152a3037b1a564a54 |
publicationDate | 2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201309723-A |
titleOfInvention | Novel eucalyptus pollen allergen |
abstract | The present invention provides a novel allergen protein of eucalyptus pollenosis, a diagnostic medicine, a preventive medicine and a therapeutic medicine for using the eucalyptus pollen allergy. The present invention is a eucalyptus pollen allergen or a fragment peptide thereof selected from the following (a) to (c): (a) a protein comprising the amino acid sequence shown by SEQ ID NO: 2; An amino acid sequence obtained by displacing, deleting or appending one or several amino acids in the amino acid sequence of SEQ ID NO: 2, and having a protein of eucalyptus pollen allergen activity; (c) comprising and SEQ ID NO: 2 Amino acid sequence having an amino acid sequence of 90% or more and having a protein activity of eucalyptus pollen allergen. |
priorityDate | 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.